Medical Weight Loss That Fits Your Life
Our personalized GLP-1 weight loss programs combine expert medical guidance, ongoing support, and medications shipped directly to your home when prescribed.
​
Semaglutide | Tirzepatide | Ozempic | Wegovy | Mounjaro | Zepbound
Medical Weight Loss That Fits Your Life
By providing the peptide the body is insufficiently providing, studies show GLP-1 inhibitors provide major benefits:
-
help curb hunger
-
weight loss
-
may lower the risk of heart disease
-
blood pressure and cholesterol levels improve (possibly due to the weight loss)
-
multiple anti-aging benefits
Studies found people using semaglutide and making lifestyle changes lost about 33.7 pounds (15.3 kilograms) versus 5.7 pounds (2.6 kilograms) in those who did not use the drug.​
​
GLP-1 is short for Glucagon-like peptide 1. GLP-1 encourages the release of insulin from the pancreas, increases the volume of cells in the pancreas that produce insulin (beta cells), and reduces the release of glucagon. GLP-1A also increases the feeling of fullness during and between meals by acting on appetite centers in the brain and by slowing the emptying of the stomach.
It has been suggested that too little GLP-1 released after a meal may increase the likelihood of, or worsen, obesity. Since GLP-1 reduces one's appetite after a meal, if the body releases less of this hormone, individuals may eat more during a meal and are more likely to snack between meals. When this peptide is mimicked by recreating it in a lab, it is a GLP-1 analogue, but in the case of semaglutide, the "a" is short for "agonist," which means the peptide binds to a receptor so it will cause a similar response to the GLP-1 that a person does not have a sufficient amount of to produce the desired effect.
​
Source: Society for Endocrinology
Source: NIH - Glucagon-Like Peptide-1 Receptor Agonists
​